evernorth glp-1 EncircleRX New Evernorth EnReachRx model expands

In our newly released white paper, From Managing Illness to Building Health, we outline why fragmented, condition-specific approaches are no longer aligned with clinical science or financial outcomes and what a more integrated, prevention-focused model looks like in practice

A new study published in April sheds light on the concerns of anesthesiologists across the United States related to the perioperative management of patients taking glucagon-like peptide-1 (GLP-1) agonists, a class of drugs now commonly prescribed for both diabetes and cosmetic weight loss

GLP-1 Probiotic does not contain GLP-1 and is not a GLP-1 agonist drug

They are commonly used in provider-guided wellness programs designed to support consistency, balanced routines, and overall metabolic efficiency

Popular weight loss drugs like Ozempic and Wegovy may cut the risk of Alzheimers disease and other forms of dementia, a large new analysis found